Lgenia Inc.

UEI
JFZLTK7QH945
CAGE
846B3
Primary NAICS
Not on record
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Subchapter S Corporation
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Website
lgenia.com
Founded
2018
Employees
11-50
Estimated annual revenue
$1M-$10M
Industry
  1. Health Care
  2. Pharmaceuticals, Biotechnology & Life Sciences
  3. Biotechnology
SIC code
28 Chemical & Allied Products
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Novel qcrb inhibitors for the treatment of tuberculosis R41AI145514 National Institute of Allergy and Infectious Diseases (NIH) -$225,343

Grant subawards

Prime recipient Prime award Amount Awarded
Trustees Of Indiana University Justification. LGENIA (www.Lgenia.com) is an Indiana-based biotechnology corporation comprised of former Eli Lilly and Company senior scientists and led by… U54AG065181 $590,921
Trustees Of Indiana University IUSM and LGENIA propose to collaborate on the optimization of SHIP1 inhibitors for the treatment of Alzheimer's Disease. LGENIA will perform iterative medicinal… U01AG088021 $619,677

Similar vendors

Vendor Location Primary NAICS
Quercus Molecular Design, LLC UEI ZHH5N3KV48A5 Avon, CT 541714 Research and Development in Biotechnology (except Nanobiotechnology)
X-Chem, Inc. UEI TEYFWDKJ48Y7 Waltham, MA 541990 All Other Professional, Scientific, and Technical Services
The Global Alliance For TB Drug Development Inc. UEI CA1RNRESAZU6 New York, NY 541714 Research and Development in Biotechnology (except Nanobiotechnology)
Crestone, Inc. UEI EDSLAP2J1BL8 Boulder, CO 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Formation Venture Engineering Foundry Inc. UEI TGUCUJNHUJA5 Topsfield, MA 541714 Research and Development in Biotechnology (except Nanobiotechnology)

See more similar vendors on GovTribe

About the company

Written by GovTribe AI ·

Lgenia Inc. is a biotechnology company that focuses on discovering new medications for debilitating diseases like Tuberculosis and Malaria, with the goal of making them affordable to all. It is registered as a for-profit corporate entity with the federal government.

Lgenia Inc. has received prime federal grant funding from the National Institutes of Health/National Institute of Allergy and Infectious Diseases to conduct research on "NOVEL QCRB INHIBITORS FOR THE TREATMENT OF TUBERCULOSIS." This project grant award was provided in 2020 with over $225,000 in funding. Additionally, Lgenia Inc. has served as a sub-awardee on grant projects led by the Trustees of Indiana University focused on research related to the "IUSM ALZHEIMER'S DISEASE DRUG DISCOVERY CENTER." Through these prime and sub-awards, Lgenia Inc. has provided expertise in drug discovery and development for tuberculosis treatment as well as Alzheimer's disease therapeutics to federal research initiatives funded by the National Institutes of Health.

Quick answers

Is Lgenia Inc. registered in SAM.gov?

Lgenia Inc.'s SAM.gov registration expired on December 7, 2021.

What is Lgenia Inc.'s most recent federal award?

Lgenia Inc.'s most recent federal grant award is Novel qcrb inhibitors for the treatment of tuberculosis (R41AI145514), from National Institute of Allergy and Infectious Diseases (NIH), on June 1, 2020.

On GovTribe

See Lgenia Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login